Navigation Links
Archimedes Pharma Receives CHMP Positive Opinion for PecFent(R) for the Treatment of Breakthrough Cancer Pain
Date:6/25/2010

READING, England, June 25, 2010 /PRNewswire/ -- Archimedes Pharma ("Archimedes"), a leading specialty pharma company, today announced that its lead product, PecFent*, has received a Positive Opinion from the Committee for Human Medicinal Products (CHMP), of the European Medicines Agency (EMA). The CHMP is recommending PecFent, an innovative fentanyl nasal spray, be authorised for marketing in European Union countries for the treatment of breakthrough cancer pain (BTCP) - sudden, unpredictable episodes of intense pain that occur despite background pain medication.

Jeffrey H. Buchalter, President and Chief Executive Officer of Archimedes Pharma, commented: "This is a defining moment for Archimedes Pharma. Breakthrough cancer pain is a poorly served indication and affects up to 95% of all cancer patients with pain. Today's announcement by the CHMP is an important step towards bringing a new treatment option to these patients in Europe. It also marks a step change in scale for Archimedes Pharma's already successful European commercial operations and an important landmark in our development as a leading global specialty pharma company. Our clinical development programme delivered excellent results and we look forward to delivering this new option for patients in Europe as soon as we can following the grant of the Marketing Authorisation."

PecFent is an aqueous fentanyl citrate solution using Archimedes Pharma's proprietary PecSys(TM) technology to allow fentanyl to be retained on the nasal mucosa and is designed to produce rapid but controlled absorption into systemic circulation. The positive opinion is based on the results of Archimedes Pharma's comprehensive clinical development programme for
'/>"/>

SOURCE Archimedes Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  Mark Farrah Associates (MFA), ... a summary of the 2015 marketplace exchange projections ... According to a recent ASPE ... Evaluation, Department of Health and Human Services) report, ... individual medical plans through the Marketplace as of ...
(Date:12/22/2014)... YORK , Dec. 22, 2014  Relmada ... novel therapies for the treatment of chronic pain, ... has been dosed in a pharmacokinetic and pharmacodynamic ... antagonist for neuropathic pain. Racemic methadone ... of various pain states and substitution therapy in ...
(Date:12/19/2014)... , December 19, 2014 ... services in the World announced the appointment of ... R. Vonsée, as Chief Channels and Partner Officer. ... since 2004 through to its acquisition by Oracle in ... Director at Geneva and subsequently ...
Breaking Medicine Technology:Insights into the Marketplace and Individual Market Growth 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 3Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4
(Date:12/22/2014)... December 22, 2014 Luxury Linen purveyor ... Partners of Dallas to provide logistics and support for ... Peacock Alley has a long history of giving back to ... sponsors of this year's Toy Drive were Whataburger® and 99.5 ... back than the holidays. Providing gifts to children who would ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 NAPW ... 2014 Professional Woman of the Year. She is recognized ... the largest, most recognized networking organization of professional women ... the National Association of Professional Women is a vibrant ... Local Chapters. , Ms. Kreider is passionate and committed ...
(Date:12/22/2014)... At the annual National League ... San Antonio, esteemed experts and thought leaders will ... in the way of successful organizational performance: resistance, ... faculty development opportunity is made possible through the ... to assist nurse educators to advance to leadership ...
(Date:12/21/2014)... Recently, BambooFlooringChina.com, a famous bamboo lumber ... flooring collection , and launched a bamboo flooring promotion ... valid until Jan. 30, 2015. , According to the ... hardest bamboo flooring available today; it has a highly ... teak hardwoods. Strand woven bamboo is made by a ...
(Date:12/21/2014)... Hills, Ca (PRWEB) December 21, 2014 ... Khanna was a guest at the Aspen Helicopters holiday ... kids and a Santa with sleigh, flown by an ... helicopter appeared invisible; only Santa with sleigh was visible.(please ... during day and night. Dr.Khanna has helped many pilots ...
Breaking Medicine News(10 mins):Health News:Peacock Alley and Community Partners of Dallas Fulfill an Estimated 12,000 Holiday Wishes for Deserving Children 2Health News:National Association of Professional Women Announces Cheryl A. Kreider, President / CEO of Kreider Health Solutions, LLC, a 2014 Professional Woman of the Year 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 3Health News:BambooFlooringChina.com Announced Its Durable Strand Woven Bamboo Flooring Collection 2
... the Support of Long Term Care elects healthcare software expert Eric Christ ... ... -- The National Association for the Support of Long Term Care (NASL) ... the president of Patient Placement Systems , part of the Jackson ...
... start for career-building in today,s tough economic times. The chiropractic ... , ... (PRWEB) December 22, 2008 ... recruiting campaign targeting career changers and other potential students. During ...
... Free Ride Home Program on New Year,s Eve , ... Terre Haute, Ind. (PRWEB) December ... with Yellow Cab of Terre Haute to provide free transportation to those who ... Year,s Eve. The Safe and Sober Free Cab Ride Home program will be ...
... 22, 2008, Cambridge, UK ,New research sheds light ... Syndrome, an inherited developmental disorder in which patients have ... study published in the journal Disease Models & ... model to help explain a puzzling connection between Costello ...
... in metabolizing the most potent carcinogen found in cigarette ... That is the conclusion of a new study published ... , a peer-reviewed journal of the American Cancer Society. ... lung cancer develops and could have important implications for ...
... Woman recently fit with the most advanced non-surgical upper extremity ... biodesigns, selective compression-stabilization interface. Amputee now feels renewed feeling of ... , ... Santa Monica, CA (PRWEB) December ...
Cached Medicine News:Health News:Eric Christ of Long-Term Care Software Leader Patient Placement Systems' Elected to NASL Board of Directors 2Health News:Parker College of Chiropractic Education Launches Recruiting Campaign for Career Changers and Potential Students 2Health News:Fleschner, Stark, Tanoos & Newlin to Offer Free Terre Haute Cab Rides on New Year's Eve 2Health News:Fleschner, Stark, Tanoos & Newlin to Offer Free Terre Haute Cab Rides on New Year's Eve 3Health News:SNPs of ABC transporter genes linked to lung cancer risk 2Health News:California Woman Receives Most Advanced, Non-Invasive Upper Extremity Prosthetic Solution: Bionic i-LIMB Hand and Innovative Interface System Increase Amputee's Functionality and Confidence 2Health News:California Woman Receives Most Advanced, Non-Invasive Upper Extremity Prosthetic Solution: Bionic i-LIMB Hand and Innovative Interface System Increase Amputee's Functionality and Confidence 3Health News:California Woman Receives Most Advanced, Non-Invasive Upper Extremity Prosthetic Solution: Bionic i-LIMB Hand and Innovative Interface System Increase Amputee's Functionality and Confidence 4
Catalyst for skin rejuvenation. Rapidly exfoliates superficial skin problems....
... simple, effective, non-surgical treatment that works by ... reducing and smoothing away frown-lines and wrinkles., ... of clinical experience. Dysport was developed in ... to successfully treat a number of neurological ...
... 18 years ago, Zyderm® and Zyplast® injectable ... filler materials for smoothing facial lines, wrinkles ... definition. Treatments supplement the skins natural collagen, ... results. Today, more than one million people ...
... into the new age of non-surgical facial ... patients immediate, long-term results for various applications ... filler offers superior versatility for a wide ... Long-lasting, Radiesse saves time and money for ...
Medicine Products: